With more rare disease therapies winning FDA approval, marketers have broadened their approach to engage families earlier in the development process.
2022 could bring about the end of the pandemic. The medical marketing community has plenty of ideas about how to accelerate the process.
As industry competition heats up, agencies are paying attention to retention, doing everything they can to keep current employees.
Data-capturing apps that monitor sleep, stress and fitness activities achieved must-have status during the pandemic. They’re here to stay.
Experts say Israel’s prowess in diagnosing and treating rare diseases is a consequence of its unusual religious and ethnic makeup.
MM+M Transform: The Patient, Provider and Payer Engagement Matrix provides the most in-depth look at the marketing and technology trends likely to influence the industry’s growth over the next year.
Get the most out of
Register for free and enjoy unlimited access to: